miR-22 has a potent anti-tumour role with therapeutic potential in acute myeloid leukaemia

por Jiang, Xi, Hu, Chao, Arnovitz, Stephen, Bugno, Jason, Yu, Miao, Zuo, Zhixiang, Chen, Ping, Huang, Hao, Ulrich, Bryan, Gurbuxani, Sandeep, Weng, Hengyou, Strong, Jennifer, Wang, Yungui, Li, Yuanyuan, Salat, Justin, Li, Shenglai, Elkahloun, Abdel G., Yang, Yang, Neilly, Mary Beth, Larson, Richard A., Le Beau, Michelle M., Herold, Tobias, Bohlander, Stefan K., Liu, Paul P., Zhang, Jiwang, Li, Zejuan, He, Chuan, Jin, Jie, Hong, Seungpyo, Chen, Jianjun
Publicado 2016

miR-196b directly targets both HOXA9/MEIS1 oncogenes and FAS tumour suppressor in MLL-rearranged leukaemia

por Li, Zejuan, Huang, Hao, Chen, Ping, He, Miao, Li, Yuanyuan, Arnovitz, Stephen, Jiang, Xi, He, Chunjiang, Hyjek, Elizabeth, Zhang, Jun, Zhang, Zhiyu, Elkahloun, Abdel, Cao, Donglin, Shen, Chen, Wunderlich, Mark, Wang, Yungui, Neilly, Mary Beth, Jin, Jie, Wei, Minjie, Lu, Jun, Valk, Peter J.M., Delwel, Ruud, Lowenberg, Bob, Le Beau, Michelle M., Vardiman, James, Mulloy, James C., Zeleznik-Le, Nancy J., Liu, Paul P., Zhang, Jiwang, Chen, Jianjun
Publicado 2012

Publisher Correction: miR-196b directly targets both HOXA9/MEIS1 oncogenes and FAS tumour suppressor in MLL-rearranged leukaemia

por Li, Zejuan, Huang, Hao, Chen, Ping, He, Miao, Li, Yuanyuan, Arnovitz, Stephen, Jiang, Xi, He, Chunjiang, Hyjek, Elizabeth, Zhang, Jun, Zhang, Zhiyu, Elkahloun, Abdel, Cao, Donglin, Shen, Chen, Wunderlich, Mark, Wang, Yungui, Neilly, Mary Beth, Jin, Jie, Wei, Minjie, Lu, Jun, Valk, Peter J. M., Delwel, Ruud, Lowenberg, Bob, Le Beau, Michelle M., Vardiman, James, Mulloy, James C., Zeleznik-Le, Nancy J., Liu, Paul P., Zhang, Jiwang, Chen, Jianjun
Publicado 2018